Shingles Vaccine Linked to Lower Dementia Risk in Nursing Home Residents
Event summary
- Study of 500,000+ Medicare beneficiaries found shingles vaccination reduced dementia risk by 24% over four years.
- Researchers used PointClickCare Life Sciences' EHR data linked with Medicare claims to analyze outcomes in skilled nursing facility residents.
- Low uptake of shingles vaccination persists among older adults in long-term care settings.
- Study published June 24, 2026 in Annals of Internal Medicine highlights need for further randomized trials.
The big picture
This study demonstrates the growing importance of real-world data in understanding complex health outcomes for aging populations. PointClickCare Life Sciences' ability to link EHR and Medicare claims creates a competitive advantage in studying underrepresented patient groups. The findings could influence both clinical practice guidelines and payer policies regarding dementia prevention.
What we're watching
- Data Utilization
- How PointClickCare Life Sciences will leverage this study to expand partnerships with researchers and pharmaceutical companies.
- Regulatory Impact
- Whether these findings accelerate FDA or CMS guidance on dementia prevention strategies in long-term care settings.
- Vaccination Trends
- The pace at which shingles vaccination rates improve among skilled nursing facility populations following this research.